U.S. Health Secretary Robert F. Kennedy Jr. plans to announce that autism is linked to the use of Tylenol during pregnancy in a report expected to be released this month, The Wall Street Journal reported today. Shares of Tylenol, made by McNeil Consumer Healthcare, a division of Kenvue, declined nearly 11% following the news.